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Abstract
Introduction: Implantable cardioverter defibrillator (ICD) recipients who suffer from posttraumatic stress disorder (PTSD) are known to be
associated with significant cardiac-specific mortality. Clinical observations suggest that PTSD is frequently undetected in ICD recipients followed up at
electrophysiology (EP) outpatient clinics. Early recognition of PTSD is important to reduce the risk of serious manifestations on patient outcomes.
Methods: All ICD recipients aged 19 years or older at the Washington University School of Medicine (WASHU) EP clinic, a large urban EP clinic,
were invited to participate in the project. An informed consent letter with an attached primary care: posttraumatic stress disorder (PC: PTSD) survey was
offered to the participants who met the inclusion criteria. Those who completed the survey were included in the project. Individuals with positive survey
result were offered a referral to mental health services. Comparisons between PTSD and non-PTSD patients were done using a two-sample t-test for
continuous variables. Using Fisher’s exact test, PTSD prevalence was compared to the study by Ladwig et al in which prevalence was determined as the
proportion of patients with positive findings of PTSD (n = 38/147). All analyses were conducted using SAS v9.4. The proportion of patients having PTSD
was determined and an exact 95% confidence interval was evaluated based on the binomial distribution.
Results: Using a convenience sample, 50 ICD recipients (33 males and 17 females) were enrolled. The project had a 30-day outcome period. Nine (18%)
of the 50 participants had positive PC: PTSD findings and all these nine participants were referred to a mental health specialist. The current project demonstrated an 18% (9/50) PTSD prevalence rate when compared to a 26% (38/147) prevalence rate in the study by Ladwig et al (P = 0.34). Although this project
did not demonstrate 20% PTSD prevalence rate, as hypothesized, the 18% PTSD prevalence rate is consistent with previous research.
Conclusion: The prevalence of PTSD noted in the current project is consistent with previous research and validates underrecognition of PTSD in
ICD patients. Offering a referral to all ICD recipients at EP clinic visits with a positive PC: PTSD screening to a mental health specialist is an important
step in reducing the risk of serious manifestations on patient outcomes.
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Introduction

Sudden cardiac death (SCD) in the United States is linked to
more than 450,000 deaths annually1 and contributes to more
than 30% (17.1 million) of all cardiovascular mortality worldwide.2 Malignant dysrhythmias such as ventricular tachycardia evolving into ventricular fibrillation cause two-thirds of
SCDs.3 An implantable cardioverter defibrillator (ICD) is the
recommended intervention for this high-risk patient population
due to its advantage over pharmacologic treatment, resulting
in a significant surge of ICDs implanted.4 Therapy has focused
on the identification of high-risk individuals for SCD including those with low ejection fraction or history of malignant
dysrhythmias.5 The ICD is designed to detect and treat these

malignant ventricular dysrhythmias through antitachycardia
pacing or shock therapy restoring a sinus rhythm.6 Survival
rates have improved over the past 20 years with ICD therapy,7
noting a 30%–50% decrease in mortality.6,8
The Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM-V), states that posttraumatic stress
disorder (PTSD) is a condition that occurs in people who
are unprotected against extreme stress or a traumatic lifethreatening event, resulting in fear, helplessness, or horror.9
A single ICD shock or an ICD storm (multiple consecutive
ICD shocks) may lead to PTSD.10 Patients who develop PTSD
attempt to avoid reminders and have frequent thoughts of the
event.11 They have consistent adverse views and expectations
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about themselves or their environment and demonstrate a
hyperarousal syndrome.11 Symptoms that persist for more
than 30 days causing impairment in day-to-day functioning
have been classified as PTSD.11
The DSM-V11 reported the US lifetime PTSD prevalence
rate of 8.7%.12 The mechanism underlying the development of
PTSD in ICD patients is not well documented.9 It is not clear
if life-threatening dysrhythmias provoke PTSD or whether
ICD shocks trigger and maintain PTSD.9
With improved SCD survival rates, a higher postrecovery
PTSD potential exists for ICD patients noting life-threatening
events.13,14 As a result, there is a relationship between adverse
cardiac events and subsequent traumatic symptoms.15 Postsurvival patients are susceptible to reexperience the cardiac
incident or ICD shocks. PTSD sufferers commonly encounter flashbacks of medical interventions and dreams of cardiac
arrest and surgical procedures. In addition, episode reminders
result in avoidance of situations causing tachycardia such as
sexual activity, exercise, and arousal symptoms triggering
obsessions with heart rate, chest pain, or insomnia.12
Many studies have suggested that an ICD increases the
quality of life (QoL) for most recipients.16 Although ICDs
improve survival rates,7 the severity of disease, comorbidities,
underlying cardiac disease, life-threatening dysrhythmia, frequent ICD shocks or electrical storms, poor social support,
younger age at implantation, gender, and/or a poor understanding of the therapy may increase anxiety, depression, and
posttraumatic stress symptoms.6,9,17 The incidence of PTSD in
ICD recipients is approximately 20% with Type D personality,
with comorbidities, and frequent shock therapy.9 According
to Shiga et al9, ICD patients with Type D personality, known
as a highly reactive stress disorder, may have an increased risk
for developing anxiety. Ventricular dysrhythmias result in the
provocation of anxiety among ICD recipients.9,18 In addition,
depression has been observed in approximately 30% of ICD
recipients, and shock therapy may contribute to the persistence of depression.9
While the recipient may perceive the ICD shock (particularly ICD storm) as traumatic, it is important to note that
the ICD population seems to differ from other PTSD populations in the development of PTSD symptoms. In non-ICD
recipients, the subsequent trauma experience is not likely. The
ICD recipient lives with the realistic and tactile threat every
second of every day.10

Nursing Focus

Nursing is concerned with the diagnosis and monitoring of
patients’ responses to health problems, with health advancement and optimization, and with the prevention of disease.19
Nurses serve a focal role in the development of interventions
aimed at improving disease response, adaptation to the disease,
and the ability to learn to live with chronic disease states.4
Nurse scientists have published a great number of studies on
the adaptation of patients following SCD, ICD implantation,
130
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and ICD shock therapy.4 It is equally important to note that
the vast majority of the behavioral and psychosocial interventions that intended to enhance QoL post ICD implantation
were developed and tested by nurse scientists.4
Nursing interventions. Nursing interventions, aimed at
decreasing the psychological stress of living with heart disease, have identified reductions in anxiety and depression.20
Medical conditions such as severe depression and anxiety disorder can be diagnosed and treated.6 Despite the acceptance of
feelings as a significant part of the human condition, scientific
knowledge of the effect of the clients’ emotions on their ability
to cope is limited.21 Cardiac disease, including complications,
will inevitably lead to a fundamental emotional reaction.6
A defense mechanism is typically the primary emotional
reaction linked to a healthy survival strategy.6 Although the
reaction demonstrates the patient’s desire to develop healthy
coping strategies, 21 it is clear that emotion affects the ways in
which the patient copes with illness.
Education. Despite the advantage of ICD technology in
survival rates, patients with an ICD experience a major disruption
in their lives.22 Guidelines for nursing care have been published,
highlighting that education is essential for ICD recipients.23
The guidelines focus on the patient’s understanding of his or her
condition, functions of the ICD, implantation procedure, preoperative and postoperative care, restrictions on activities of daily
living, and discharge instructions.22 The underlying supposition
is that the patient will process and understand the information
received as well as adapt to daily life activities.24

Review of Literature

An extensive literature search using Center for health evidence
(CCHNE.net), CINAHL, ClinicalTrials.gov, Cochrane,
Embase, Guidelines.gov, Medline, PubMed, and OVID was
undertaken to search for publications describing PTSD in
ICD recipients. Each database was searched for the most current evidence-based data, randomized controlled trial (RCT),
systematic reviews including Evidence-based Practice Center,
and Health Technology Assessment reviews and meta-analyses
conducted between the years 2000 and 2015. Cohort or other
prospective non-RCT designs were also considered. A total of
26 guidelines and systematic reviews arrived at diverse conclusions, provided different recommendations, and observed
different effectiveness of therapies, 25 regarding PTSD in ICD
patients. However, many guidelines identified trauma-focused
psychological treatments as a preferred method viewing medications as an adjunct or a next-line treatment.25 The range of
participant inclusion criteria included the assessment of one of
the following outcomes: PTSD symptoms, remission (no longer having symptoms), QoL, disability or functional impairment, or adverse events. Settings included outpatient and
inpatient care, cardiovascular, electrophysiology (EP) clinic,
primary care, and mental health care settings.
Ladwig et al.26 found that experiencing SCD outside of
the hospital setting resulted in an even greater prevalence of
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PTSD (27%–38%) among ICD recipients. A total of 48.6%
of the sample had clinically significant levels of PTSD at
any one point in time.26 ICD recipients with positive PTSD
scores after device implantation were considerably more likely
to have shock storm.27 These rates dropped significantly in the
first six months after ICD implantation to 15% and remained
stable at one year.27 von Känel et al.28 found a 31% prevalence of PTSD in ICD patients two years post implantation.
At five and a half years post ICD implant, the PTSD prevalence had increased to 36%.28 A total of 19% of the participants
had PTSD at both assessments, 12% had PTSD at baseline,
and 18% had PTSD at the follow-up visit.28 Likewise, elevated PTSD scores were associated with a 3.2 times greater
likelihood of mortality within five years compared with ICD
patients, with no to moderate symptom levels of PTSD, even
after controlling for disease and demographic parameters.26
Moreover, Ladwig et al.26 reported that the relative mortality
risk was 3.45 (adjusted for age, gender, diabetes, left ventricular ejection fraction, beta-blocker use, depression, and anxiety)
in ICD recipients with PTSD (high Impacts of events scalerevised (IES-R) score) compared with those without PTSD.
Ladwig et al.26 found that prior ICD shocks had no
influence on the experience of PTSD symptoms. In addition,
Kapa et al.27 found that ICD recipients with shocks and those
without shocks differed only in their scores on physical component of the short form-36 health survey (SF36). Therefore,
regardless of the occurrence of ICD shock, the experience of
cardiac arrest, or being told of the potential threat, there is no
evidence highlighting the incidence of PTSD in the first year
after implantation.27

Methods

PTSD in ICD recipients is known to be associated with
55% cardiac-specific mortality. 29 It is important to recognize PTSD symptoms early in this patient group due to the
high risk of mortality and morbidity and equally important to
ensure that they receive appropriate care to reduce their risk of
detrimental outcomes. Clinical observations and an exhaustive
literature review suggest that PTSD is frequently undetected
in ICD recipients followed up at EP outpatient clinics. There
were no known studies at the time of this project that screened
ICD recipients all-inclusively, regardless of indication for the
ICD implant on behalf of PTSD symptoms utilizing the PC:
PTSD screen in the outpatient EP clinic. The focus of the
project was to develop and implement a PTSD protocol using
the PC: PTSD tool.
In our project, similar to the Ladwig et al.26 study, age and
gender were evaluated. However, the baseline cardiovascular
disease state and indication for ICD implant were excluded
intentionally. The current project focused on screening all ICD
recipients, regardless of ICD indication with the PC: PTSD
tool for symptoms of PTSD in the outpatient EP clinic. The
focus of the Ladwig et al.26 study was to evaluate for PTSD
symptoms at baseline and predict long-term mortality risk

in patients with ICDs. Although the focus of the study was
different, both studies were performed in a similar urban and
suburban outpatient clinic and all participants were screened
for PTSD symptoms. Our project evaluated the PTSD prevalence and was compared accordingly in which prevalence was
determined as the proportion of patients with positive symptoms of PTSD. Based on the previous research by Ladwig
et al.26, implementing the PC: PTSD screening tool to ICD
recipients in an EP outpatient clinic would demonstrate a
greater than 20% prevalence of PTSD.
Following the institutional review board’s approval from
the University of Alabama in Huntsville, Alabama, Washington
University School of Medicine (WASHU) in St. Louis,
Missouri, who approved a partial waiver of HIPAA authorization, the patients were screened for PTSD using the
validated PC: PTSD tool (Appendix A). Patients older
than 19 years of age, with an ICD, were eligible for inclusion in the project. The exclusion criteria included combative
or confused patients without family support. The patients were
asked to review the consent letter (Appendix B) and complete the attached PC: PTSD screening tool (Appendix A).
ICD patients, who agreed to participate, were screened during their follow-up visits. All of the participants were identified through the electronic medical record (AllScripts) and
recruited at WASHU in the EP clinic during their Usual
customary care (UCC) visit. The research was conducted in
accordance with the Declaration of Helsinki.

Implementation

Phase I of the project began with a presentation detailing the
project goals, interventions, and expected outcomes to senior
leadership, nursing management, and multidisciplinary office
staff. A consent letter with the attached PC: PTSD screening
tool was reviewed in detail (Appendices A–B). The PC: PTSD
screening tool was developed by Annabel Prins et al. 30 (2003)
and was designed for use in primary care or other medical
settings to screen for PTSD. It is a four-question tool that
includes an introductory sentence, prompting respondents
regarding traumatic events. Prins et al. 30 (2003) suggested
that any PC: PTSD screen should be considered positive for
most participants with three “yes” responses to any item in
the screen.
Phase II of the project began with the completion of the
administration and provider and staff training. Patients were
identified using Allscripts, Washington University’s electronic
medication record. All patients with an ICD aged 19 years and
older were given the informed consent letter with the attached
PC: PTSD survey. By the end of 12 days, 50 participants had
completed the attached survey. Nine of the 50 participants
had positive findings on the screening. Each patient with a
positive PC: PTSD survey was referred to a mental health
specialist for further evaluation and treatment. We expected
a 20% prevalence rate of PTSD in the EP outpatient clinic of
the participating patients.
Clinical Medicine Insights: Cardiology 2016:10
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Phase III of the project began when enrollment of
50 participants was met. SAS v9.4 software was used to calculate the prevalence of PTSD in ICD recipients in the EP
outpatient clinic, and all data were compared to the work by
Ladwig et al.26, demonstrating a greater than 20% burden.
The project coordinator tracked this information.

Framework

The biopsychosocial model (BPS), used as the framework for
this project, assisted medical personnel in facilitating and/or
promoting healthy client behaviors.31 BPS entails the conceptualization and treatment of health problems as an interplay
between biological factors, psychological factors, and social factors, culminating in the manifestation of symptoms.32 The BPS
is predicted to be the best theoretical framework capable of
establishing a therapeutic process or producing an antitherapeutic effect on ICD patients suffering from PTSD.33 Screening to identify ICD recipients who are currently suffering or are
at risk of PTSD signifies the need for comprehensive, superior
care, consistent with BPS.31 The BPS allows healthcare professionals to expand their analyses, diagnoses, and treatment
of illness.34
Evidenced-based interventions with proven patient
outcomes are essential in clinical practice.4 Nursing leadership requires promoting change and expanding the nurses’
scope of practice. This requires the nurses to demonstrate
leadership and educational reform in their practice.4 The
Institute of Medicine Report on “The Future of Nursing:
Leading Change Advancing Health” endorsed the need
for nurses to coordinate care among clinician and healthcare agencies, prevent occurrences of acute care episodes,
and be involved in managing chronic illness and disease
progression, resulting in prevention of rehospitalization. 35 Nurses are in an optimal position to affect important disease outcomes for patients and their families after
ICD implantation.4

Evaluation

In this project, a structured PTSD screening protocol using
the PC: PTSD tool was administered to all ICD patients in
a large EP outpatient clinic in the Midwestern United States.
A 30-day time frame was utilized to obtain consent and screen
participants. The data were extracted from the electronic
health record used in the facility.
Project costs. The costs of materials and staffing time
were eliminated, as the health administrators determined that
the evaluations of PTSD in post ICD implants met the current standard of care. There were no salary costs associated
with the project.

Results

The purpose of this analysis was to determine the prevalence
of PTSD among patients with ICD implants seen during
outpatient EP clinic visits and to establish a referral protocol
132

Clinical Medicine Insights: Cardiology 2016:10

to mental health services for any positive PC: PTSD screen.
A positive response to the PC: PTSD screen was defined
by three “yes” responses to any of the four screen questions.
The proportion of patients having PTSD and an exact 95%
confidence interval based on the binomial distribution are
presented in Table 1. Comparisons between PTSD and
non-PTSD patients were done using a two-sample t-test
for continuous variables and Fisher’s exact test for categorical statistics (Table 2). PTSD prevalence was compared to
Ladwig et al. 26 study prevalence using Fisher’s exact test
(Fig. 1). In the Ladwig et al. 26 study, prevalence was determined as the proportion of patients having a positive PTSD
result (n = 38 of 147). All analyses were conducted using
SAS v9.4.
A total of 50 ICD recipients (33 male and 17 female)
participated in the project. A total of 18% of the participants had a positive PC: PTSD screen. Each participant
with a positive PC: PTSD screen, nine patients in total,
was referred to mental health specialists for further evaluation and treatment. When evaluating the PTSD symptoms from the time of the ICD implant (2009–2015), an
increased burden of PTSD symptoms was observed in the
group of participants with ICD implanted in 2015 (26%),
compared to those with ICD implanted in 2009 (6%; Fig. 2).
The evaluation of the responses to the PC: PTSD question
demonstrated significant findings (Fig. 3). A total of 26% of
the overall patient group experienced nightmares during the
previous 30 days (P = 0.001). Within the same patient group,
31% reported symptoms of avoidance (P = 0.001). A total
of 20% of these patients reported that they felt on guard
(P = 0.001) and 24% of this group documented that they felt
numb (P = 0.001). Ladwig et al. 26 study reported a notable
26% incidence rate compared to an 18% prevalence in the
current sample (P = 0.34). This project did not demonstrate
a 20% prevalence of PTSD symptoms as initially hypothesized. However, the project did demonstrate a significant
18% burden of PTSD.

Discussion

Growing evidence suggests that PTSD symptomatology is
highly prevalent in EP clinic and harmful to psychosocial and
physical health. The current project supports the need for routine screening for the presence of PTSD in the outpatient EP
clinic based upon the evidence found in the literature review
and project findings. Utilization of the PC: PTSD screen as
Table 1. Prevalence of PTSD in the outpatient EP clinic.

Positive PC:PTSD
Screen = Yes

Frequency/
Total = Percent

95% CI

9/50 = 18%

(8.6%, 31.4%)

Note: The proportion of patients having PTSD and an exact 95% confidence
interval based on the binomial distribution.
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Table 2. Summary of statistical findings.
Overall PC:PTSD

Age

Variable (N = 50)
PC:PTSD

62.28 + 15.68

Screen = NO
PTSD

64.93 + 13.10

Screen = Yes
PTSD

50.22 + 21.98

Gender No. (%)

P-value

0.08
1.00

F

17 (34%)

14 (34%)

3 (33%)

M

33 (66%)

27 (66%)

6 (67%)

2009

3 (6%)

3 (7%)

0 (0%)

2010

6 (12%)

4 (10%)

2 (22%)

2011

3 (6%)

2 (5%)

1 (11%)

2012

7 (14%)

4 (10%)

3 (33%)

2013

13 (26%)

12 (29%)

1 (11%)

2014

5 (10%)

5 (12%)

0 (0%)

2015

13 (26%)

11 (27%)

2 (22%)

ICD Implant Year, No. (%)

0.30

Q1 Had nightmares, No. (%)

,0.001

NO

37 (74%)

37 (90%)

0 (0%)

YES

13 (26%)

4 (10%)

9 (100%)

Q2 Avoidance, No. (%)

,0.001

NO

34 (69%)

34 (85%)

0 (0%)

YES

15 (31%)

6 (15%)

9 (100%)

Q2 On guard, No. (%)

,0.001

NO

40 (80%)

40 (98%)

0 (0%)

YES

10 (20%)

1 (2%)

9 (100%)

Q2 Felt numb, No. (%)

,0.001

NO

37 (76%)

36 (90%)

1 (11%)

YES

12 (24%)

4 (10%)

8 (89%)

Referral made (Positive PC: PTSD Screen), No. (%)

,0.001

NO

41 (82%)

41 (100%)

0 (0%)

YES

9 (18%)

0 (0%)

9 (100%)

Note: Comparisons between PTSD and non-PTSD patients were done using a two-sample t-test for continuous variables and Fisher’s exact test for categorical
statistics.

a standard of care in an EP clinic on all ICD recipients would
help identify patients at increased risk for PTSD. Early
recognition and referral to a mental health specialist provides
comprehensive, superior care. Given the known association of
increased morbidity and mortality in patients with cardiovascular disease and PTSD, this recommended practice standard
becomes imperative for improved patient outcomes such as
reducing the likelihood of future ICD shocks and increased
mortality risk.

Limitations

The findings from this study should be interpreted in light
of several limitations. First, the study sample was relatively
small and located in a large EP outpatient clinic in an urban
community. While this is an important group to study,
given their underlying all-inclusive cardiac indicators for the

recipient’s implantable cardiac defibrillator, these results may
not generalize to other populations. Second, though the PC:
PTSD tool is a validated measure of PTSD, it has never been
studied looking at the operating characteristics in the EP outpatient clinic to screen for PTSD symptoms.

Summary

There is an urgent need for a multidisciplinary approach to
care for ICD recipients with PTSD symptoms as was demonstrated by the current project. The increased prevalence
of PTSD in ICD patients measured by this study as 18%
supports the need and is consistent with previous research.
PTSD symptoms are a key source of emotional distress in
patients with ICDs. These symptoms may persist for years;
therefore, they should not be overlooked. EP clinicians
should screen regularly for PTSD symptoms, and those with
Clinical Medicine Insights: Cardiology 2016:10
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Comparison rates of prevalence between Roberts current project and
Ladwig et al. 2008 study
50
147

147

40

126

40

105

109

84

Roberts 2015

30

Ladwig et al. 2008

20

Q1: Nightmares

37

37
34

Q2: Avoidance
Q3: On Guard
Q4: Felt Numb

63
13

10

50

42

41

0
9

0
Total enrollment

10

38

21

NO PTSD

YES PTSD

Figure 1. PTSD prevalence rate comparison.
Notes: PTSD prevalence was compared to Ladwig et al’s, (2008), study
prevalence using Fisher’s exact test (Fig. 3). In the Ladwig et al’s, (2008)
study, prevalence was determined as the proportion of patients having
a positive PTSD result (n = 38 out of 147). All analyses were conducted
using SAS v9.4.

15

NO response

12

YES response

Figure 3. ICD recipient response to the PC: PTSD screen.
Notes: Twenty-six percent of the overall patient group experienced
nightmares during the previous thirty days (P = 0.001). Within the same
patient group, 31% reported symptoms of avoidance (P = 0.001). Twenty
percent of these patients reported that they felt on guard P = 0.001). Twentyfour percent of this group documented that they felt numb (P = 0.001).

Author Contributions

20

Overall patient
group

15

11

10

3 3
0

2009

YES PTSD
group

7

6

5

NO PTSD
group

13

13
12

55
4
2

2010

3

4
2

1
2011

3

2012

1
2013

2
2014

2015

Figure 2. Prevalence of PTSD per the ICD implant year.
Notes: When evaluating the PTSD symptoms from the time of the ICD
implant (2009 to 2015), an increased burden of PTSD symptoms was
observed in the group of participants with ICD implanted in 2015, (26%)
compared to those with ICD implanted in 2009, (6%).

positive results should be referred to a mental health specialist. Improved integration of mental health services in the
EP clinic will better serve these high-risk patients. Future
research is needed to validate the global prevalence of PTSD
in EP clinics with ICD recipients. Subsequently, the magnitude of PTSD could be fully evaluated to determine if patient
education and a referral protocol to mental healthcare services decrease the prevalence of PTSD and prevent detrimental health outcomes.
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